BAT5906 not checked

Bio-Thera Solutions

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
5 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Diabetic Macular Edema (DME)
Main trialPhase 3
“A multicenter, randomized, double-blind, parallel-group, active-controlled non-inferiority trial. A total of 406 subjects with diabetic macular edema (DME) were planned for enrollment. After screening, eligible subjects were randomized in a 1:1 ratio to the treatment group or the control group. The treatment group received BAT5906 injection, while the control group received Lucentis®. During the trial, ophthalmic examinations and safety assessments were conducted according to the protocol for efficacy and safety evaluation. Blood samples were collected for immunogenicity assessment. The…”In the company’s words, NCT07515079 on ClinicalTrials.gov
Other names
No Other Intervention Names
Copy of
Lucentis (Genentech)Tested side by side with the original in NCT05439629, NCT07515079

Other drugs for Diabetic Macular Edema (DME)

All 12 drugs for Diabetic Macular Edema (DME)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Apr 2027 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Phase 3Completed 22 Apr 2025 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
Phase 2Completed 6 Sep 2022 Clinical Study on the Efficacy and Safety of BAT5906 Injection
Phase 1/2Completed 6 Nov 2023 Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema
Phase 1Completed 28 Feb 2021 A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BAT5906

Following is part of Solo: you see every change to BAT5906 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in